Meeting · chair Iris

meeting open, no fills to log — book flat since 06-29, daniel's gs/gild/cme basket never reached the floor. two things for the room: cash 1.63%, ~37bps under the 2% floor, still un-swept, zero t+1 buffer; and cme now -1609bps, ~391bps off the -2000 stop-loss line and closing — was ~549 on 06-26. nothing tripped, no rejects. handing to the chair.

Rates: 10-year 4.44, back up 6bps on the week off the 4.38 low. 10-year reals 2.20, eased off the 2.29 cycle high but firmly above 2.00 — the real-rate squeeze holds, low-vol stays ON, nowhere near the 1.90 trigger. 2s10s 31bps, still 2y-led (2y 4.14, cuts pulled forward, not growth priced). Funds 3.63 parked, FOMC patient into the July print. Nothing in the curve says the cutting cycle has genuinely turned.

Dollar/oil: Broad dollar firm at 120.9. WTI $71.87 — the collapse continued, down from ~$79 last week and $108 in mid-May. The energy hedge has fully deflated; that helps headline CPI on the goods side but does nothing for shelter/services stickiness. China's demand impulse is soft — the oil tape is telling you that, not a supply glut alone.

Credit/vol: OAS 2.74, drifting sideways after a peek at 2.83 on 06-26 — still complacent, my watch toward >350 is not triggered. VIX 16.6, back down — equity vol calm, no credit stress.

Tilt unchanged 8th week: low-vol ON, cash-flow-today over multiple, quality over junk. Label: late-cycle defensive.

Regime (riding Priya 07-02): late-cycle / restrictive reals / credit still complacent. Reals 2.20 (off the 2.29 cycle high, firmly above 2.00 — nowhere near the 1.90 low-vol-off trigger). 10yr 4.44, 2s10s 31bps but 2y-led (cuts pulled forward, not growth). OAS 2.74 — a hair off the 2.83 local wide, still complacent. VIX 16.6. WTI collapsed to ~$72 from $109 six weeks ago — the energy inflation-hedge leg has deflated hard. Low-vol stays ON. Factor wall unchanged since 06-18: quality cash-flow-yield core; the marginal name must be β≥1.10 quality-cyclical, no faked beta off the ETN.

Gross: ~98%. Cash is 1.63%, ~37bps under the 2% floor and un-swept — zero T+1 buffer. I am NOT levering a floor-constrained book; the first job is rebuilding the SGOV residual to ~2-3%, which means the next add is funded from a trim, not cash.

Where I'm happy: V (+9.6%, +32.8bps active) and GIS (+11.7%, +25.2bps) are the two names carrying the book — quality cash-flow-yield working exactly as the frame says. Keep them.

Where the book has to move — three things: 1. CME is the priority cut, not a discretionary one. Ops flagged it -1609bps, ~391bps off the -2000 stop line and closing; -16.1% since entry, -37.7bps active, β0.26 dead-money low-vol financial. It bounced +5.6% on 07-01 to $231 — that's the exit window, not a reason to hope. My standing cut candidate since 06-18; the GS/CME basket never filled, so it's still sitting here bleeding. Cut it this session — it funds the residual AND removes the worst drag in one trade. I'll sponsor the close. 2. IT is -7.2pp underweight and the single largest active drag (-6.1bps active inception, -34.4bps raw) — a non-position. The structural fix is a β≥1.10 quality tech name: cures the beta floor, closes the IT gap, advances toward the 18-name floor. Top-left of my 2x2. Margaret to hunt it. 3. Financials is band-binding — 17.9% NAV, +4.9pp over SPY, ~1.4x benchmark against the 1.6x cap, and the largest active drag at sector level. Cutting CME relieves it. No new Financials name this week — I don't add to the tilt that's costing us.

Factor 2x2 for the room:

Top-left is the whole game: one β≥1.10 quality tech name funded off the CME close is the single trade that cures cash floor + IT gap + beta floor + count. Everything else waits.

Triggers carry: OAS>350 → cut first cyclical (XOM/FDX); reals<1.90 + 10yr<4.30 → ease low-vol + migrate ETN right-side (reals 2.20, 10yr 4.44 — not there). Energy note: WTI ~$72 guts the XOM inflation-hedge rationale — XOM -8.3%, -14.3bps active; it's on watch as the OAS>350 first-cut candidate alongside FDX.

Risk envelope — the concentration map. Single-name cap is 3.5% of NAV (the one hard gate). Only one active name is near it: V at 3.33% — ~5bps of room, so an add there or a rally past ~$369 could bump it. Everything else sits 1.0–2.5%. No creep worth blocking this week.

What policy WON'T catch, and the committee owns. Top-5 is 87.5% and SPY alone is 76.7% of the book — but that's the passive core, not an active bet, and top-5-ex-SPY is benign. No sector caps breached: Financials 17.9% is our biggest active tilt (+4.9pp vs SPY, 4 names) and it's already cost us -12.9bps active since inception, CME the wound at -37.7bps. Tech is 23.8%, still 7pp UNDER SPY — the true drag is being underweight it. These are judgment tilts, on the record, not gate trips.

Mid-week flags I'd call. CME breaks -2000bps stop-review (live tape ~-12%, ~780bps away — a watch, not a trigger). Cash 1.63% un-swept is a live floor breach with zero T+1 buffer — first thing to cure. And any GS-type add that pushes Financials tilt harder without trimming CME.

The book keeps validating one thing: cash-flow yield with a hard quality filter is what's paying. GIS is +11.7% and V +9.6% since inception — my two biggest active contributors — while the junk-adjacent and no-cash-flow names bleed. That's the theme I'm still hunting: subscription-like or membership-like economics that compound through a cycle, bought when the tape divorces from the franchise. GS on the 06-29 dislocation was that trade; it never filled, and it's still the shape I want. Where conviction has MOVED: CME is broken on the mark, -16.1% and -40bps active, the textbook recycle — I want that seat freed for a name that earns its beta. BMY and GILD hold conviction 4 as cash-flow-today ballast — $14B and $10B OCF, fwd single-to-mid-teens — but GILD's second leg still needs a β≥1.15 quality name to seat over the floor. Watchlist, not-yet-in-book: I'm re-screening industrials and financials for one high-beta quality name that clears the wall. XOM I'm watching, not adding — energy hedge deflating with WTI under $80 doesn't fix the -8% mark. Reals at 2.20 still punish anything without cash flow today; I won't reach for multiple.

The GILD leg is mine to defend, and nothing about it has moved. I filed it as a resize, not a standalone add, on purpose: it's the pre-committed second β0.33 low-vol ballast leg from my 06-18 factor wall, and it only seats when a β≥1.15 quality name lands in the same basket to carry it over the 0.90 floor. We proved on 06-25 that GILD→2.0% vetoes solo (beta 0.899); it clears only paired. GS is that carrier this session — GS's β1.29 dollars lift GILD's β0.33 leg over the floor, gate confirms 0.9006. So GILD rides with GS or not at all; it is not a name I'd top up on its own at this beta. On the franchise, my read is unchanged and I'm comfortable: ~39% operating margin, ~$10B operating cash flow, ROE ~43%, forward ~15x — cash-flow-today ballast, exactly the low-vol quality Priya's frame calls for with reals at 2.20 and low-vol ON. Conviction 4. To the vote as part of the basket.

On the GILD leg, from the regime seat: reals 2.20 firmly above 2.00, low-vol ON, nowhere near the 1.90 trigger — a second β0.33 low-vol ballast leg fits the frame cleanly, no reservation. But it only earns its seat paired. GILD's β0.33 dollars can't be sourced by faking beta off the ETN into restrictive reals at the 2.20 squeeze — I've held that wall since 06-18. GS's β1.29 quality-cyclical dollars are the honest carry, and CME out cures the cash floor in the same trade. So GILD→2.0% only clears as the basket, not standalone. AYE the resize inside the 3-leg. Solo, it re-breaks the 0.90 floor and I'd have nothing to say for it.

GILD 1.01%→2.0% is a resize of a name already in the book, not a new exposure. On roughly 1pp of NAV added, a -10% move in GILD costs about $1.0k — 10bps of NAV. This is β0.33 low-vol ballast; it doesn't move the risk needle on its own.

The only thing to watch is that it only clears paired. Basket confirmed live: would_clear TRUE, zero breaches, beta 0.9058→0.9006 holds the 0.90 floor — GS's β1.29 dollars carry GILD's β0.33 leg over the line. Standalone it re-breaks the floor; inside this basket it doesn't. Cash 1.63%→3.76% cures the sub-floor breach. Bounded, and paired it's clean. Approved from the risk seat.

VOTE: approve

eod 07-02 meeting. no fills, book flat since 06-29 — 11 active, nav 987,186, cash 1.63% still ~37bps under the 2% floor, un-swept. gild leg on the floor: resize 1.01%->2.0%, +0.99pp = ~$9,760 = ~78 sh @ 125.97. β0.33 ballast, ~10bps of nav on a -10% move per iris, adv ~7m so the clip is noise. leg only clears paired inside the basket — gild solo pulls beta toward the 0.90 floor; cme close funds it and cures the cash breach same trade. gild not in an earnings freeze. asked the chair for gs working style. no fills, no breaks.

VETOED — GILD 2.00% did NOT fill: portfolio beta band — Portfolio beta 0.899 outside [0.9, 1.15]. Resize, pair an offsetting name, or hold it for a future session.

The GILD leg vetoed standalone — beta 0.899, under the floor, exactly the pairing dependency I flagged. So Daniel's #69 is the honest restructure: close CME paired with GS 2.5%, drop GILD rather than fight it. CME is my worst detractor and my standing cut since 06-18 — a β0.26 dead-money financial, -16.1% since entry, -37.7bps active. I checked the wire: CEO succession (Fitzpatrick) and analyst growth notes, no broken-franchise crack, but no thesis left to defend on a β0.26 name that's led financial-sector losers. Crystallizes ~-$4.0k realized, a loss already on the mark. GS's β1.29 quality dollars carry the floor AND cure the sub-2% cash breach in the same trade — upgrading a β0.26 drag to a cheap quality cyclical on a week-held real dislocation. I vote CME out.

On CME close from the regime seat: AYE, and cleanly. CME is a β0.26 dead-money financial — my standing cut since 06-18 — and closing it does two things the frame wants. It recycles β0.26 dead weight into GS's β1.29 quality-cyclical dollars, and it cures the 1.63% sub-floor cash breach in the same trade, T+1 buffer restored. GS at a week-held dislocation is quality-cyclical, not junk-beta — fits late-cycle/restrictive with reals firmly >2.00 and low-vol ON. GILD dropped standalone is correct; no faked beta off the ETN into the 2.20 real-rate squeeze. Nothing to add for CME standalone — it's the honest funding source.

The restructure is the honest one — GILD dropped after it vetoed standalone, and GS's β1.29 dollars carry the beta this time. I ran the basket live: would_clear TRUE, zero breaches. Beta 0.9058→0.9072 holds the floor, cash 1.63%→3.76% cures the sub-floor breach in the same trade, top-5 84.1%, count holds 11.

GS 2.5% ≈ $24.7k. Loss path: -10% gap on the 07-14 print ≈ $2.5k / 25bps NAV; a -15% stop ≈ $3.7k / 37bps. Print is 12 days out, outside the T+1 freeze. CME close crystallizes ~-$4.0k already sitting on the mark — realized, not new risk. Tape confirms GS held $1,019 flat across five sessions off the $1,013 low — a dislocation that stuck, not a high chase.

Carrying standing: 11 vs the 18-name minimum (un-gated, on the record) and the cash floor needs the SGOV sweep post-fill. Bounded, cures a live breach, upgrades a β0.26 drag. Approved from the risk seat.

VOTE: approve

eod 07-02 meeting. no fills, book flat since 06-29 — 11 active, nav 987,186, cash 1.63% still ~37bps under the 2% floor, un-swept. gild #67 vetoed standalone (beta 0.899). daniel refiled #69: cme close paired with gs 2.5%. fill math — cme -95.04 sh @ ~231 crystallizes ~-$4,026 realized, β0.26 out, raises ~$21.9k; gs ~24 sh @ 1,019.61, β1.29 in. beta 0.9058->~0.9072 on the floor, cash cures 1.63%->~3.76% in the same trade, top-5 ~84%, count holds 11. cme is deepest detractor -37.7bps active / -16.09% since entry. sequencing: cme sell leads, gs buy follows, t+1 settle. cme i work vwap, gs style pending the chair. no breaks.

VETOED — CME 0.00% did NOT fill: minimum holdings — 10 positions (min 18). Resize, pair an offsetting name, or hold it for a future session.

The CME close vetoed on the 18-name floor — closing it drops us 11→10, under the minimum, which kills the funding leg. Daniel's right to restructure one last time to what actually clears: GS 2.5% open, standalone from cash. I ran it live myself — check_proposal_risk GS 2.5%: would_clear TRUE, zero breaches. So it holds.

The one tension I'll name so it's on the record, not buried: standalone doesn't cure the sub-2% cash floor the way the paired version did — we lean on the SGOV sweep to rebuild the residual, and the book stays at 11 vs the 18-name floor. That's a headcount hold, not an advance, and CME stays in as a β0.26 drag I still want gone the next session it can be recycled without breaking the floor. I take the trade anyway.

On the business: Goldman Sachs is the β1.29 cheap quality cyclical the campaign has waited on since 06-18 — $1,019.61, ~9% off the $1,125 52w high, on the 50d ($995), well above the 200d ($887), a full week holding the dislocation without a franchise crack. FY25 (SEC XBRL): NI $17.18B, dil EPS $51.32, equity $125B, ROE 14.6%; TTM EPS +24% YoY, rev +14.5%; fwd 17.2x, P/B 2.74. Not junk-beta — quality on a held pullback. Q2 prints 07-14, 12 days out, outside the T+1 freeze — buying off the high WITH runway, not the FDX night-before binary. Stop: Q2 miss on a franchise line (IB/trading rev down y/y), ROE structurally <11%, or -15% rel. AYE.

AYE on GS 2.5% standalone — the fit is unchanged from every session since 06-18. Frame verbatim 8th week: reals 2.20 firmly >2.00 (NOT through 1.90), 10yr 4.44, 2s10s 31 2y-led, OAS 2.74, VIX 16.6, low-vol ON. GS is cheap-ish β1.29 quality cyclical on a week-old dislocation ($1,020, ~9% off the high) — not junk-beta, exactly the name the frame wants. Standalone from cash it ADDS β1.29 dollars, so the 0.90 floor is never at risk here; the beta was never the standalone problem — GILD's carry was, and dropping it is right.

One flag from my seat, and it's the cash floor, not the fit: cash sits 1.63%, ~37bps sub-floor and un-swept. GS at ~$24.7k drawn from $16.1k cash re-breaks the floor unless it's part-funded off the SPY-core trim. CME can't fund it — it won't fill on the 18-name minimum. So the honest funding is a partial SPY trim, not cash to zero. I defer the exact mix to Daniel, but the residual has to land back inside [2%,10%] or this trades a beta cure for a cash breach. Fit AYE; funding must not zero the residual.

The trade changed under me. #69 cured the 1.63% cash breach by funding GS off CME — CME won't fill on the 18-name floor, so this is now GS 2.5% from cash, standalone. I re-ran it live: would_clear TRUE, zero breaches. Beta 0.9058→0.9127 holds the floor on real GS β1.29 dollars. Count 11→12, top-5 85.1%.

But cash stays 1.63% — the sub-floor breach the earlier basket cured is NOT cured here; funding from cash leaves it un-swept and ~37bps under the 2% floor. The gate doesn't veto that, so it's a flag, not a block. Ops sweeps to floor next session.

Loss path: GS 2.5% ≈ $24.7k. Q2 prints 07-14, 12 days out, outside the freeze — a -10% print gap ≈ 25bps NAV, a -15% stop ≈ 37bps. GS held the $1,019 dislocation a full week, not a high chase. Bounded, holds the beta floor, upgrades to β1.29 quality. I'll wear it. VOTE: approve.

eod 07-02 meeting. no fills, book flat since 06-29 — 11 active, nav 987,186, cash $16,119 = 1.63%, still ~37bps under the 2% floor, un-swept. cme close #69 vetoed on the 18-name minimum (11->10), which killed the funding leg. daniel restructured to gs 2.5% standalone from cash; iris/margaret re-ran would_clear TRUE, beta 0.9058->0.9127. ops flag on the record: the standalone version can't fund clean — gs 2.5% is ~$24,680 against a $16,119 cash pile, so it drives cash negative rather than curing the sub-floor breach the cme-funded version fixed. asked the chair the funding source: partial gs sized to available cash, or a pairing trim. gs held the 06-26 dislocation ($1,019.61) a full week, back to same level 07-01 — 24 sh is noise, work vwap no skew, q2 07-14 outside the freeze. no rejects beyond the cme veto, no breaks.

FILLED — BOUGHT 24 GS @ $1034.92 (now ~2.46% of NAV), funded by trimming the SPY block. Book: 12 names, SPY ~74.2%, cash $16,502. This name is set — no need to re-table it.

Close — chair, from the risk seat. Frame held verbatim an 8th week: late-cycle, reals 2.20 firmly above 2.00, 10yr 4.44, OAS 2.74, low-vol ON — GS is a cheap-ish β1.29 quality cyclical on a week-old dislocation.

Traded: GS 2.5% standalone from cash carried 4-0 and FILLED — 24 sh @ $1,034.92, ~2.46% of NAV, funded by an SPY-core trim (not cash). Book: 12 names, SPY ~74.2%, beta lifts 0.9058→0.9127. Vetoed: the CME close (18-name floor, 11→10), which killed the original funding leg.

Open on the table: cash still 1.63%, ~37bps under the 2% floor, un-swept — CME couldn't cure it. Ops sweeps SGOV next session. Loss path on GS bounded: -10% Q2 gap 07-14 ≈ 25bps NAV, print outside the freeze; I'll wear it.

Lena — the minutes are yours.